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Abstract. A number of factors have been implicated in 
the regulation of tissue-specific collagen fibril diameter. 
Previous data suggest that assembly of heterotypic 
fibrils composed of two different fibrillar collagens rep- 
resents a general mechanism regulating fibril diameter. 
Specifically, we hypothesize that type V collagen is re- 
quired for the assembly of the small diameter fibrils ob- 
served in the cornea. To test this, we used a dominant- 
negative retroviral strategy to decrease the levels of 
type V collagen secreted by chicken corneal fibroblasts. 
The chicken or(V) collagen gene was cloned, and ret- 
roviral vectors that expressed a polycistronic mRNA 
encoding a truncated otl(V) minigene and the reporter 
gene LacZ were constructed. The efficiency of viral in- 
fection was 30--40%, as determined by assaying I~-galac- 
tosidase activity. To assess the expression from the re- 
combinant provirus, Northern analysis was performed 
and indicated that infected fibroblasts expressed high 
steady-state levels of retroviral mRNA. Infected cells 
synthesized the truncated or(V) protein, and this was 
detectable only intracellularly, in a distribution that 
colocalized with lysosomes. To assess endogenous 
etl(V) protein levels, infected cell cultures were as- 
sayed, and these consistently demonstrated reductions 
relative to control virus-infected or uninfected cultures. 
Analyses of corneal fibril morphology demonstrated 
that the reduction in type V collagen resulted in the as- 
sembly of large-diameter fibrils with a broad size distri- 
bution, characteristics similar to fibrils produced in 
connective tissues with low type V concentrations. Im- 
munoelectron microscopy demonstrated the amino- 
terminal domain of type V collagen was associated with 
the small-diameter fibrils, but not the large fibrils. 
These data indicate that type V collagen levels regulate 
corneal fibril diameter and that the reduction of type V 
collagen is sufficient to alter fibril assembly so that ab- 
normally large-diameter fibrils are deposited into the 
matrix. 
T 
HE characteristics  of different extracellular matrices 
derive in large part from the synthesis,  assembly, 
and deposition of collagen molecules and their or- 
ganization into unique macromolecular structures. These 
collagen assemblies  confer specialized  properties  to the 
extracellular matrix in which they are found. The cornea, 
for example, has small, uniform diameter fibrils organized 
into orthogonal lamellae;  these characteristics  permit this 
tissue to be strong yet transparent. 
The synthesis  of collagen molecules and their associa- 
tion to form fibrils requires a number of sequential post- 
translational events that are common to all fibrillar  col- 
lagens (19). These include intracellular processes  such as 
hydroxylation and  glycosylation,  and  extracellular ones 
such as procollagen processing  and cross-linking  (14, 19, 
30). Fibril assembly may be modified through the associa- 
tion  of different fibrillar  collagens  to  form heterotypic 
fibrils (3, 5, 15, 18, 24), the addition of proteoglycans to 
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form collagen-proteoglycan  heteropolymers (33, 39), or by 
the addition of fibril-associated  collagens  to fibrils  (19). 
Alternative splicing of collagens also can occur in a tissue- 
specific manner and confer different properties to fibrils 
(27,  32,  35,  37). Tissue-specific  variations  in  all  these 
events contribute to the diversity of collagen  structures 
observed in different extracellular matrices. 
Fibril assembly is a multistep process and, as such, there 
are numerous points where fibril characteristics,  i.e., diam- 
eter, may be regulated. Propeptide processing  represents 
one such  checkpoint. The C-propeptides of procollagen 
molecules are cleaved in the extracellular matrix before 
incorporation  of  collagen  monomers  into  fibrils,  and 
therefore C-propeptidase activity provides an early rate- 
limiting  step in fibril formation (14, 30). N-propeptidase 
activity varies  with collagen  substrates, being rapid with 
type I collagen yet limited with type III (28, 31). A unique 
example of this propeptidase regulation exists with hetero- 
typic type I/V fibrils. Type I collagen in these fibrils is fully 
processed while type V is only partially processed,  using a 
distal cleavage site that leaves the bulk of the noncollage- 
nous amino-terminal domain intact (20). 
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I/V  fibrils  in  a  molecular  arrangement  that  leaves  the 
amino-terminal domain exposed on the surface and the 
major triple-helical portion of the molecule located within 
the  fibril (20).  Between the  major  triple  helix and  this 
amino-terminal domain lies a  "hinge region" and three 
small triple-helical domains that we have previously sug- 
gested  permit  the  extension  of  the  amino-propeptide 
through the hole zone and onto the fibril surface (20). This 
structural arrangement observed in heterotypic type I/V 
fibrils exists with other fibrils as well. Type II collagen 
fibrils, for example, contain type XI collagen molecules, 
and these are positioned in a way that the amino-terminal 
domains project onto the fibril surface. As with type V col- 
lagen, the triple-helical domains are within the fibril (24, 
29, 42). The similarities between collagen types V and XI 
extend beyond a structural resemblance: in certain tissues 
(e.g., vitreous, bone)  type V  collagen molecules can be 
comprised of both type V and type XI a chains, suggesting 
that type XI chains are able to substitute for type V chains 
(12).  Given these structural and functional similarities, it 
has been suggested that these two collagens comprise part 
of a larger fibrillar collagen family, one that has a predom- 
inantly regulatory rather than structural function (12, 22). 
Fibril diameter is related to the concentration of type V 
collagen within heterotypic type I/V fibrils, and it is the 
amino-terminal domain that appears to confer this regula- 
tory property. Previous self-assembly studies have demon- 
strated that in vitro, the levels of type V collagen incorpo- 
rated into type IN fibrils is inversely proportional to fibril 
diameter:  the  higher  the  concentration  of type  V,  the 
smaller the diameter. It also was shown that if the amino- 
terminal domain is removed, diameter regulation is abol- 
ished. It is hypothesized that the presence of the amino- 
terminal surface component is able to block accretion of 
collagen  monomers  and,  hence,  limit  growth  (20).  Al- 
though these in vitro studies demonstrated a strong rela- 
tionship between type V concentration and fibril diameter, 
the smallest diameters achieved were larger than those ob- 
served in situ (4). 
To test in vivo the hypothesis that the concentration of 
type V collagen is sufficient to control diameter, we used 
a  dominant-negative retroviral approach to alter the lev- 
els of or(V) collagen and thus perturb the type I/V col- 
lagen ratios within heterotypic fibrils. We reasoned that 
the synthesis of a truncated ctl(V) chain, possessing only 
the C-propeptide and a portion of the triple helix, would 
be functional in chain assembly and yield hybrid triple- 
helical molecules composed of both truncated and endog- 
enous et chains. These would be targeted to degradative 
pathways and thereby reduce the concentration of type V 
collagen (30,  41).  The results demonstrate that reduced 
type V collagen levels in corneal fibroblasts lead to the as- 
sembly and deposition of abnormally large fibrils into the 
extracellular matrix. 
Materials and Methods 
Cloning of al(V) Collagen Carboxyl Terminus 
The carboxyl terminus of cd(V) collagen was cloned using 3' RACE pro- 
cedures using 14-d cornea total RNA as the template. A poly(T)-adapter 
primer was used in the initial reverse-transcription reaction to generate 
eDNA. This was followed by PCR amplification using the same 3' primer 
and a 5' primer specific to a region within the triple-helical domain of the 
al (V) mRNA (5' GGGAAGACAGGCCCAATCGGCC 3'). PCR-ampli- 
lied eDNA was cloned into the TA vector (Invitrogen, San Diego, CA), 
and purified DNA was subjected to sequence analysis using the dsDNA 
Cycle Sequencing System (GIBCO BRL, Gaithersburg, MD). 
Replication-defective Retroviral Vectors 
Retroviral vectors were kindly provided by Dr. Takashi Mikawa (Cornell 
University Medical College, New York, NY). These vectors are derived 
from spleen necrosis virus (SNV)  1, a member of the avian reticuloendo- 
theliosis virus group. The vectors are replication defective and, to produce 
infectious particles, must obtain missing proteins in trans from packaging 
cells (10, 25). Once assembled in these cells, this virus is capable of infect- 
ing a wide variety of host cells. Since horizontal transmission of the virus is 
not possible in nonpaekaging cells, only progeny of infected cells will ex- 
press the proviral transcripts. The pCXIZ vector contains the SNV pro- 
moter as well as sequences required for encapsidation of viral transcripts, 
reverse transcription, and proviral integration (26). In addition, this vector 
contains an internal ribosome entry sequence followed by the bacterial 
LacZ gene. For efficient expression of this reporter gene in eukaryotic 
cells, a translation initiation sequence derived from the murine leukemia 
virus gag gene is present in the 5' flanking sequence. A  cloning site is 
present upstream of the internal ribosome entry sequence region and was 
used for insertion of the al(V) collagen eDNA. The pCXL vector is simi- 
lar to pCXIZ, but lacks the internal ribosome-binding sequence (25). This 
vector was used as a control. 
Constructs 
PCR splicing by overlap extension was used to add myc and signal se- 
quences in frame to the al(V) carboxyl terminus. The myc sequence was 
also obtained from Dr. Takashi Mikawa. The al(V) signal sequence 
was obtained from the published chicken pro-~l(V) sequence (20).  To 
add the myc sequence, a 5' 93-mer was made that encoded a SpeI site, the 
myc sequence, and the sequence overlapping the 5'  end of the al(V) 
eDNA  (5'TCGATCACTAGTGC'ITGGGCGACCTCACCATGGAGC 
AAAAGCTCAITrCTGAAGAGGACTTGAATGCCCITCCAGGA- 
TCCCCTGGCCCAGATG 3'). A poly(T)a0 primer was used at the 3' end 
of the  otl(V)  eDNA,  and  PCR  amplification generated  a  mye-al(V) 
eDNA. Digestion with SpeI produced a 1,244-bp  fragment with a 3' end 
terminating just downstream of the stop codon. 
The al(V) signal sequence was added to the 5' end of this myc-ut(V) 
eDNA fragment using a similar approach. Initially, the prowl(V) signal 
sequence (and upstream translation initiation sequence) was PCR ampli- 
fied using a 5' primer overlapping the signal sequence and possessing a 
SpeI 5'  extension (5'TCGATCACrAGTGTGGACCATGGATACGCA- 
CACGCGATG 3'), as well as a 3' primer encoding part of the signal 
sequence and an extension that would overlap with the myc sequence 
(5'  CATGGTGAGGTCGCCCAAGCAGAGGTCTGCAGGTFCAGC- 
TGC 3'). PCR amplification generated a 157-bp product encoding the sig- 
nal sequence. This was annealed to the myc-ctl(V) eDNA and amplified 
by PCR using the same 5' primer and a 3' primer overlapping the stop 
codon  and  carrying  a  SpeI  3'  extension (5'TCGATCACTAGTGGT- 
GGCTCITAGCCCATGAAG  3') to generate a  1,381-bp  product. This 
ctl(V) "minigene" was inserted into the SpeI-compatible XbaI site in the 
pCXIZ vector. 
Production of  High Titer Recombinant Virus 
The generation of infectious viral particles was achieved by transfection of 
packaging cells (NND17.2G)  with the recombinant vectors using Lipo- 
feetamine (GIBCO BRL; 10). This packaging cell line was derived from a 
canine osteosarcoma (D17; 9, 40). A total of 2 p,g DNA comprised of re- 
combinant vector and a pSV2-neo selection vector (in a  35:1 ratio) was 
used to transfect 2  ×  104 packaging cells in 30-mm dishes. Selection was 
achieved using eDMEM containing 400  i~g/ml (active units)  Geneticin 
(G418) for a 2-3-wk period. Clones were isolated using cloning cylinders 
and expanded. Virus was harvested from confluent monolayers of packag- 
ing cell clones, and was frozen in small aliquots in fiquid N2. To determine 
1. Abbreviations used in this paper. SNV, spleen necrosis virus; TU, trans- 
ducing units. 
The Journal of Cell Biology, Volume 135, 1996  1416 viral titers, chicken embryo flbroblasts were plated sparsely onto gridded 
60-mm dishes. Aliquots of virus were used to infect the cells for 2--4 h in 
the presence of 10 p.g/mi polybrene (Sigma Immunochemicals, St. Louis, 
MO). 2 d  after infection, the cells were fixed in 2% paraformaldehyde/ 
PBS, and positive cells were identified using an assay for 13-galactosidase 
activity (22). Frozen aliquots of virus were used at a concentration of 2-6 
×  106 transducing units (TU)/ml. 
Infection of Corneal Fibroblasts 
Corneal fibroblasts (from first to fifth passage) were infected with ~5  × 
los TU of virus in the presence of 10 p.g/ml polybrene. Uninfected control 
cells also were cultured in the presence of polybrene. After infection for 5 h, 
media were changed and the ceils cultured for at least 48 h until confluent. 
Cell Culture 
Corneal fibrobtasts from 14-d embryonic white leghorn chickens were iso- 
lated and cultured as described previously (23). Briefly, cells were isolated 
after bacterial collagenase treatment and were maintained in cDMEM 
containing 10%  FBS (GIBCO BRL)  and 50 p~g/ml aseorbate after the 
ceils became confuent. Cells were trypsinized and split 1:2 or 1:3. Corneal 
fibroblasts also were cultured within three.dimensional bovine type I col- 
lagen gels (Vitrogen 100; Collagen Corp., Palo Alto, CA) as described 
previously (7, 8). Briefly, cells were trypsinized and counted, then placed 
in wells containing 0.5 ml of 0.75 mg/ml neutralized Vitrogen in complete 
media at a concentration of 104 cells per well. The collagen solution was 
polymerized at 37°(2 such that the cells were suspended in the gel. The 
edges of the collagen gels were released after overnight culture, allowing 
the gels to contract. Previously, we have extensively characterized this sys- 
tem for studies of collagen fibrillogenesis, and the newly assembled col- 
lagen fibrils are easily distinguishable from the bovine matrix (7, 8). 
Protein Analysis 
Infected and uninfected 14-d chicken embryo corneal fibroblasts were cul- 
tured in monolayer cultures as described. At confluence, the fibroblasts 
were incubated for 4 h in cDMEM containing 1% FBS and ascorbate (50 
p~g/ml). Universally labeled [14C]proline (5 p,  Cffml) was added, and the in- 
cubation was continued for an additional 20 h. Media were collected, the 
cell layer was rinsed twice with PBS, pooled with the media, and brought 
to 0.5 N  acetic acid. Cell layers were scraped in 0.5  N  acetic acid and 
brought to pH 2.5 with HCI. Media and cell layer were digested two times 
with pepsin (50 p~g/ml)  over 24 h at 4°C. For electrophoretic analysis, load- 
ing was normalized to (a) constant pepsin-resistant clam for analysis of col- 
lagen type I/V ratios; and (b) constant DNA content for analysis of type I 
levels. DNA was analyzed using Hoechst 33258  (Pierce Chemical Co., 
Rockford, IL) according to the manufacturer's instructions and a TKO 
Fluorometer (Hoefer Scientific Instruments, San Francisco, CA). Samples 
were separated by electrophoresis on 6% SDS-polyacrylamide gels, dried, 
and exposed to BioMax film (Eastman Kodak, Rochester, NY). The films 
were scanned using the Eagle Eye II System (Stratagene, La Joila, CA) 
and  densitometric  analysis  was  performed  with  Scanalytics  software 
(ONE-Dscan, ver. 1.0; CSP, Inc., Billerica, MA). Quantities of types I and 
V collagen and the I/V ratio were determined by measuring the et2(I) and 
al(V) bands, respectively. 
Northern Analyses 
Total RNA was isolated from 14-d corneal fibroblasts infected with the 
al(V) minigene--containing virus and control virus (containing only the 
lacZ sequence), and from uninfected cells. For each, confluent layers of fi- 
broblasts grown in 100-ram  dishes were used and infected with approxi- 
mately 5  ×  10  s TU  of virus.  RNA was isolated using Trizol  (GIBCO 
BRL). Total RNA (5-10 p.g) was loaded and run on 1% formaldehyde- 
agarose gels. RNA was transferred to nylon filters (Hybond; Amersham, 
Arlington Heights, IL) and blots were probed with nick-translated cDNA 
fragments  from  cd(V)  and  cd(I)  collagen,  the  retroviral  vector,  and 
G3PDH. Each Northern contained an RNA ladder (Promega, Madison, 
WI) as a size standard. 
Western Analysis  for the Endogenous and Truncated 
al(V) Chains 
To characterize the expression of the truncated protein, Western analysis 
was performed as described above on a 6--20% gradient gel with a mono- 
clonal anti-myc antibody (MYC1-9E10.2;  11). Infected and uninfected 14-d 
chicken embryo corneal fibroblasts were cultured for 24  h  in cDMEM 
containing 1% FBS and ascorbate. Media was collected, and the cell layer 
was rinsed twice with PBS and pooled with the corresponding media. The 
cell layers were scraped in PBS. To determine whether the truncated pro- 
tein was found in the cell layer, media, or both, comparable amounts of 
concentrated media and cell layer extracts were blotted onto nitrocellu- 
lose and probed either with a monoclonal anti--e-myc antibody to identify 
the truncated protein, or with a polyclonal anti-al(V) antibody to specifi- 
cally identify the endogenous protein. Detection was by ECL chemilumi- 
nescence and exposure to BioMax film. 
Immunofluorescence Analysis of Truncated 
t~l(lO Protein 
Infected and control corneal fibroblasts cultured on plastic or within col- 
lagen  gels were fixed with  4%  paraformaldehyde/PBS and  methanol, 
quenched with 50 mM glycine/lysine, and blocked with 1%  BSA/PBS. 
Cells were incubated for 1 h  with anti-myc primary antibodies and fol- 
lowed with a second 1-h incubation with a fluorescein-conjugated second- 
ary  antibody. For localization of lysosomes, cells were incubated with 
rhodamine-conjugated dextran (Molecular Probes, Eugene, OR) at a con- 
centration of 1 mg/ml for 2 h. The medium was changed, and the cells 
were viewed 24--48 h later. Cells were mounted in FITC Guard (Testog, 
Inc., Chicago, IL) and photographed. 
Transmission EM 
Corneal fibroblasts in collagen gels were processed for transmission EM 
as described previously (7). Alternatively, collagen gel cultures were pro- 
cessed for preembedding immunoelectron microscopy as described previ- 
ously (7). The following mAb were used: anti-J~-galactosidase (GIBCO 
BRL); anti-myc (myel-9E10.2; 11); anti-type I collagen antibodies, I-BA1 
and I-DD4 (17, 36); and an anti-NH  2 type V antibody (20). Sections were 
cut, stained with 2% aqueous uranyl acetate and 1% phosphotungstic, 
pH 3.2, and viewed with a transmission EM (CM10; Philips Technologies, 
Cheshire, CT). 
Analysis of  Fibril Diameter 
To determine the diameter of assembled fibrils in collagen gel cultures, 
fibrils that were adjacent to cells were selected. In addition, fibrils from 
immunolabeled sections and conventional plastic sections were analyzed. 
Diameters were measured from calibrated micrographs, and  measure- 
ments were normalized using the internal 67-nm repeat of the fibrils. 
Results 
Construction of a Retroviral Construct Containing an 
al(V) Minigene 
Reducing the endogenous ed(V) collagen levels using  a 
dominant-negative retroviral  strategy required  the  con- 
struction of an al(V) minigene that would be capable of 
associating with endogenous ct chains to form hybrid mol- 
ecules  (strategy outlined in Fig. 1). We designed a trun- 
cated ed(V) minigene containing an or(V) translation ini- 
tiation and signal sequence that would direct synthesized 
protein to the secretory pathway, a myc peptide sequence 
to provide an epitope tag that could be used to identify 
mutant protein, and the carboxyl terminus of the etl(V) 
chain including a portion of the triple helix and the entire 
C-propeptide (Fig. 2 A). 
To obtain the carboxyl terminal region of or(V)  col- 
lagen that is required for chain assembly, the carboxyl ter- 
minus  of chicken  al(V)  collagen was  cloned  using  3' 
RACE procedures. The coding sequence of the 1,360-bp 
cDNA that was obtained was verified using PCR cycle se- 
quencing for both strands.  The predicted amino acid se- 
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Figure 1.  Targeted reduction of type V collagen using a domi- 
nant-negative approach. The dominant-negative  strategy chosen 
to reduce the levels of type V collagen was designed to express 
high levels of a truncated c~ chain that would compete with the 
endogenous a  chains for assembly into triple-helical molecules. 
The truncated ~  chain is translated  from what  is effectively a 
polycistronic message containing the cd(V) minigene, an internal 
ribosome binding sequence, and a reporter gene encoding 13-galac- 
tosidase. The truncated al(V) sequence is directed to the secre- 
tory pathway for subsequent chain assembly, while 13-galactosidase 
remains in the cytoplasm. The mutant-endogenous  hybrid trimers 
formed are expected to be targeted to degradative pathways. With 
high expression of the mutant chains, the concentration  of func- 
tional type V molecules, composed entirely of native ct chains, 
would be decreased. 
quence from this clone has 390 residues from the carboxyl 
terminus and is composed of 267 non-triple-helical amino 
acids and 123 amino acids from the triple-helical domain 
(Fig. 2 B). This sequence has been submitted to GenBank/ 
EMBL/DDBJ and has the accession number U39621. To 
deliver this minigene to cells, the construct was inserted 
into  SNV-based,  replication-defective retroviral vectors. 
Retroviral particles containing this  minigene  have  been 
designated "MVZ." Control virus carrying only the LacZ 
gene has been designated "CXL." 
Infection Rates for Recombinant Viral Particles 
Are High 
To assess the infection rates for the recombinant viral par- 
ticles, corneal fibroblasts were infected in vitro and  as- 
sayed for cytoplasmic  [3-galactosidase  expression.  Virus 
(MVZ or CXL) was harvested from confluent monolayers 
of packaging cells and used to infect chicken corneal fibro- 
blasts.  The  infection  and  culturing  conditions  we  used 
yielded infection rates of 31)--40% for the MVZ virus and 
~40% for the CXL virus, demonstrating a high rate of in- 
fectivity for these cells. 
Northern Analysis Demonstrates High Steady-state 
Levels of Retroviral Transcripts 
To assay expression from the retroviral vectors, Northern 
analyses were performed (Fig. 3). Cells infected with the 
MVZ virus expressed high levels of the truncated ed(V) 
mRNA (5.6 kb) relative to the endogenous or(V) mRNA 
(7.9 kb). This was not observed in CXL-infected or unin- 
fected cultures. When probed with a 3' ed(V) cDNA (Fig. 
3 A),  hybridization was  observed to both the  truncated 
and endogenous al(V) mRNAs, with the truncated form 
predominating. Although the endogenous al(V) mRNA 
level appears high with this probe, this is caused by non- 
specific vector hybridization that comigrates with the en- 
dogenous etl(V)  mRNA  (see  below).  The ed(V)  levels 
were more easily compared when a 5' probe specific for 
the endogenous mRNA was used (Fig. 3 B). Levels were 
relatively uniform in infected and  control cultures, with 
the two virus-infected cultures showing a ,~10% decrease 
relative to uninfected cultures. When blots were probed 
with the vector cDNA (Fig. 3 A), expression was high in 
both the CXL-infected and MVZ-infected cultures, with 
the size increase (4.1 to 5.6 kb) in the latter caused by the 
al(V)  minigene  insertion.  As  described above,  there  is 
some slower migrating hybridization present in the viral- 
infected lanes but not in the uninfected lanes. The hetero- 
geneity of this  larger,  nonspecific hybridization is  most 
likely a result of the length and sequence differences that 
are present in the two mRNAs (with or without minigene), 
and is not observed in uninfected cells. 
To determine whether viral infection influenced endog- 
enous collagen expression, we analyzed ¢tl(I) message lev- 
els in MVZ-infected and control cultures (Fig. 3 B). When 
probed with an etl(I) cDNA,  mRNA  levels in both the 
MVZ and CXL cultures were slightly reduced (10-15%) 
relative to the  uninfected cultures.  Some variability was 
observed, however. In five RNA preparations, the two ex- 
tremes demonstrated both an increase and a  decrease in 
etl(I) expression in MVZ infections relative to the con- 
trols. The other three preparations demonstrated the small 
but constant decrease (10-15%) in both MVZ- and CXL- 
infected cultures. 
Mutant al(V) Protein Is Expressed in 
MVZ-infected Cells 
Western  blot  analyses  using  antibodies  directed against 
the myc sequence included within the construct demon- 
strated the expression of a  54-kD protein specifically in 
the MVZ-infected cells (Fig. 4). The size is larger than the 
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GTGGACCATG  GATACGCACA  CGCGATGGAA  AAC-C~GCAGT  TGGATACGGA  50 
ACTGGCAGCT  GCACGTCGCG  CTGGTGCTGC  T~GCCGC  GGCCCT~  i00 
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CAGCCTCTGC  CCATCCAGTC  TTCCAAGAGG  ACCAGGCGAA  ACATCGACGC  600 
CAGCCAGCTG  GTGGACGATG  GAAACGCTGA  CAACTACATG  GACTATGCAG  650 
ATGGCATGGA  GGAAATCTTC  GC-CTCACTGA  ATTCCTTGAA  ACTGGAAATT  700 
GAACAAATGA  AGCATCCATT  GC-GCACTCAA  CATAACCCAG  CTCGTACCTG  750 
CAAGGATCTC  CAGCTCTGTC  ACCCTGATTT  CCCAGATGGT  GAATACTGGG  800 
TGGATCCTAA  CCAAGGATGT  TCCAGGGACT  CTTTCAAAGT  GTACTGTAAT  850 
TTCACAGCTG  GTGGAGAGAC  TTGCATCTTC  CCTGATAAGA  AGTCTGAAGG  900 
AGCTAGAATT  ACTTCTTC-C~  CAAAGGAAAA  CCCAC-GCTCC  TGGTTCAGTG  950 
AATTCAAGCG  CGGTAAACTG  CTCTCCTATG  TGGATTCGGA  TGGGAACCCC  i000 
ATCGGAGTGG  TACAGATGAC  GTTCCTCAGG  CTGCTGAGTG  CCTCGGCCCA  1050 
CCAGAACATC  ACTTACAACT  GCTACCAGTC  CGTAGCCTGG  CACGATGCCA  ii00 
CCACTGACAG  CTACGACAAG  GCCATCCGCT  TCCTGGC~TC  CAACGACGAG  1150 
GAGATGTCCT  ACGACAACAA  CCCCTACATC  CGAGCTGCAT  TCGATGGCTG  1200 
CGCGGCAAAG  AA~TATC  AGAAGACTGT  CCTGGAAATC  AACACGCCCA  1250 
AGGTCGAGCA  AGTGCCTATC  GTCGACATCA  TGTTCAATGA  CTTCGGAGAA  1300 
GCATCACAGA  AATTTGGATT  CGAGGTGGGA  CCAGCTTGCT  TCATGGGCTA  1350 
A  1351 
Figure 2.  Construction  of  an  al(V) 
minigene. The carboxyl terminus of the 
chicken etl(V) collagen was cloned and 
used  to  construct  a  truncated  ctl(V) 
minigene.  The  region  of  the  eDNA 
used in the retroviral constructs  con- 
tained  123  amino acids  of the triple- 
helical  domain  and  the  entire  267- 
amino acid-long non-triple-helical C- 
propeptide domain. The al(V) signal 
sequence and translation initiation  se- 
quence was added to the 5' end of the 
eDNA, and a myc sequence was added 
just  downstream  of  this  signal  se- 
quence (A). The sequence of the entire 
construct is presented in B. Bold type, 
ctl(V) translation initiation  sequence; 
single  underline,  al(V)  signal  se- 
quence; double underline, myc peptide 
sequence;  dotted underline, cd(V) tri- 
ple-helical  region;  upper case,  entire 
ed(V) carboxyl propeptide sequence. 
predicted 43 kD (49 kD with the signal peptide), and this 
can be attributed to posttranslational modifications (there 
are two potential sites for N-linked glycosylation) and to 
the  altered  electrophoretic  mobility  observed  with  col- 
lagens.  The protein was present  in the  cell layer of the 
MVZ-infected,  but  not  of the  control-infected  or  unin- 
fected cultures.  Using dot-blot analyses, no protein  was 
detected in the media of the cultures, even when concen- 
trated,  suggesting  that  the  protein  remains  cytoplasmic 
(data not shown). 
Mutant al(V) Protein Remains Intracellular and Is 
Localized to Lysosomes 
To determine the location of the mutant protein, infected 
and  control  cells  cultured  in  three-dimensional  collagen 
gels were examined by immunofluorescence using an anti- 
body directed against the myc tag. In MVZ-infected cul- 
tures, positive cells showed reactivity throughout the cyto- 
plasm (Fig. 5), frequently with a punctate distribution. As 
expected  from the  Western  analysis,  no  signal  was  ob- 
served extracellularly in the collagen gel or in the CXL- 
infected or -uninfected cultures. 
To determine if the truncated ~tl(V) protein was in the 
degradative  pathway,  double-labeling  experiments  were 
performed. Rhodamine-conjugated dextran was used as a 
lysosomal marker, and myc antibodies were used to local- 
ize the mutant or(V) protein. The signals overlapped (Fig. 6), 
indicating that mutant proteins become localized to the ly- 
sosomal compartment within the infected cells. There was 
no signal for the mutant protein in the control cells. 
Type V Collagen Synthesis Is Reduced in Infected Cells 
Type V  and type I collagen levels were measured in cells 
that had been infected with the MVZ virus, CXL control 
virus, or from uninfected cells. Infection rates were 40% 
for CXL and ~30% for the MVZ virus. The data demon- 
strate  a  ~25%  reduction  in  type V  collagen  relative  to 
type I  collagen in the MVZ-infected cultures when com- 
pared to the control virus-infected and uninfected cultures 
(Fig. 7). Specifically, there were 24.2 +_ 8.0 and 6.3  +  9.8% 
(mean _  SEM, n  =  7) reductions in the MVZ- and CXL- 
infected cultures, respectively. This indicates a specific re- 
duction in type V  collagen in cells expressing the type V 
minigene. 
The decrease in the type IN  ratio seen in  the  MVZ- 
infected cells was further assessed by examining the abso- 
lute  collagen  levels.  The  et2(I)  and  or(V)  signals  were 
measured in infected cultures and normalized to DNA con- 
tent. A decrease of N28% in the type I levels was observed 
in both virus-infected cultures (CXL and MVZ). The den- 
sity values for the et2(I) chain for MVZ, CXL, and unin- 
fected cultures were 0.47  +  0.13,  0.47  _  0.07, and 0.64  _ 
0.11, respectively (mean _  SD, n  =  6). A  decrease in type 
V  collagen also was observed in both virus-infected cul- 
Marchant et al. Type V Collagen Regulates Collagen Fibril Diameter  1419 NORTHERN ANALYSIS OF INFECTED CORNEAL FIBROBLASTS 
A 
~eo.--~ 
PROBES:  (I 1  (V)-3' 
,,4 
Vec-- 
VECTOR 
B  aqv)-- 
G3PDH-- 
(11(V)-5' 
al(t)- 
G3PDH--  ~ 
(xl(I) 
7.gkb 
4.gkb 
Figure 3.  The  al(V)  mini- 
gene expression  is high com- 
pared to endogenous cd(V) 
collagen.  Northern  analysis 
of 14-d corneal fibroblasts in- 
fected with  the MVZ virus, 
CXL control virus, and from 
uninfected  cells  (U/).  Blots 
were  probed  with  eDNA 
fragments  encoding  the 
al(V)  carboxyl  terminus 
(al(V)-3') and the vector se- 
quence  (A),  and  fragments 
encoding  the  al(V)  amino 
terminus  (al(V)-5')  and 
etl(I) collagen  (B).  For nor- 
malization,  all  blots  were 
probed  with  a  G3PDH 
cDNA.  Cells  infected  with 
the  al(V)-containing  virus 
(MVZ)  demonstrated  high 
levels of the 5.6-kb truncated al(V) mRNA (A, arrow labeled Aal(V)/LacZ A). Infected and control cells all had comparable levels of 
endogenous al(I) and cd(V) mRNAs (B) when normalized to a signal obtained from a G3PDH probe. When probed with the vector 
eDNA (A), expression was high in the MVZ-infected and CXL-infected cells, with the size increase in the former because of the al(V) 
minigene insertion. No signal was observed in uninfected cells. 
tures relative to the uninfected  cultures.  However, there 
was a  further decrease in the MVZ-infected cultures  re- 
suiting from expression of the minigene. This MVZ-spe- 
eific effect resulted in the alterations observed in the type 
IN ratio. The density values were 0.26 _  0.03, 0.37 _  0.08, 
and 0.42 __. 0.08 for MVZ, CXL, and uninfected cultures, 
respectively (mean  _  SD, n  =  6). Taken together, these 
data demonstrate a reduction of type V  collagen relative 
to type I collagen, specifically in the MVZ-infected cultures, 
but not in the control virus-infected or -uninfected cultures. 
Collagen Fibril Morphology Is Altered in Cells 
Expressing the al(IO Minigene 
To assess the effects of the al(V) minigene expression on 
fibril assembly, collagen fibrils assembled by infected cells 
cultured in collagen gels were examined. Previous studies 
(7) have demonstrated that corneal fibroblasts cultured in 
three-dimensional collagen gels synthesize tissue-specific 
collagens and assemble fibrils with diameters comparable 
to those observed in situ.  Fibroblasts isolated from 14-d 
~,~lp  Figure  4.  The  truncated 
~'~'~ ~  cd(V) protein is expressed in 
infected  cells. Western  blot 
207  analysis of MVZ- and CXL- 
N  139  infected  and uninfected  (U/) 
84  cell  extracts  demonstrates 
r~kO---t,  the  presence  of  a  protein 
41.r  with  an  apparent  molecular 
32  mass of 54 kD specifically in 
the  MVZ-infected  extracts. 
This  size  is  consistent  with 
that predicted from the pri- 
mary  amino  acid  sequence 
and  likely  posttranslational  modifications.  This  band  is  not 
present in the control virus-infected or uninfected  cell extracts. 
Western blots from reduced SDS-PAGE gradient gels (6--20%) 
were  probed using  an  antibody directed  against  the  myc tag 
present within the mutant cd(V) protein. 
corneas were infected with either the  MVZ or CXL vi- 
ruses and seeded into such three-dimensional gel cultures. 
Assays for 13-galactosidase activity performed on parallel 
cultures indicated  that infection rates were again ~30%. 
This generated both infected and uninfected cell popula- 
tions for morphological analyses. 
To evaluate the effects of viral infection quantitatively, 
fibrils were measured from a number of infected cells cul- 
tured within the collagen gels. Infection was verified using 
anti-13-galactosidase  immunostaining,  and  measurements 
were made  on fibrils that were immediately adjacent  to 
the positive cells (Fig. 8). Control (CXL  ÷) cells produced 
normal fibrils with respect to diameter and size distribu- 
tion (mean =  24 nm), indicating that viral infection itself 
had no effect on fibril morphology. A  total of 31  fibrils 
were measured from seven positive cells. The morphology 
of the fibrils synthesized by these cells was indistinguish- 
able  from the  uninfected  cells  (data not  shown).  MVZ- 
infected cells (MVZ+), in contrast, produced large-diame- 
ter fibrils with a size distribution from 20 to 65 (mean = 
37.2) nm. Data were collected from 14 cells and 62 fibrils 
were measured. 
Since viral infection rates were 30%, it was possible to 
measure  fibrils  assembled  by  individual  MVZ-infected 
and uninfected cells within the same culture.  Uninfected 
(MVZ-) cells produced "normal" 24-nm fibrils, while the 
fibrils  assembled  by  infected  cells  (MVZ ÷)  produced 
large-diameter fibrils with a broad size distribution ranging 
from 20 to 60 nm (mean  =  44 nm; Fig.  9).  Several large 
diameter fibrils were visible in  extracytoplasmic channels 
within these cells (2), clearly defining the cell producing them. 
Previous studies  in  our laboratory have demonstrated 
that the amino-terminal domain of type V collagen, within 
heterotypic type I/V fibrils is exposed on the fibril surface. 
We therefore analyzed the infected cultures using intmu- 
noelectron  microscopy  with  antibodies  directed  against 
this  exposed domain.  The small diameter fibrils showed 
significant reactivity for type V collagen while the large di- 
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Figure 6.  Expression of the truncated etl(V) protein is localiz~ 
to  lysosomes.  Double-label  immunofluorescence  was  used  to 
demonstrate that the mutant ed(V) protein is localized to the ly- 
sosomal compartment. Infected and control corneal fibroblasts 
were double labeled with rhodamine-conjugated dextran to iden- 
tify the lysosomal compartment, and with anti-myc antibodies to 
identify the truncated cd(V) protein. The signals from the mutant 
¢d(V) protein (anti-myc fluorescein, left column) and lysosopa~ 
(dextran-rhodamine, right column) were superimposable in MVZ- 
infected cultures. As expected, the CXL and uninfected cultures 
had no myc label, but the lysosomal compartment was labeled. 
Bar, 20 p~m. 
ameter  fibrils  did  not  (Fig.  10).  Both  fibril  populations 
were positive for chicken type I collagen (data not shown). 
These morphological data indicate that the content of type V 
collagen is reduced in fibrils assembled by the MVZ-infected 
cells, and that this reduction is sufficient to alter fibril as- 
sembly in such a way that abnormally large fibrils are de- 
posited into the matrix. 
Figure 5.  The truncated etl(V) protein remains intracellular.  An- 
tibodies directed against the myc peptide tag were used to local- 
ize the mutant etl(V) protein in corneal fibroblasts cultured in 
bovine  type  I  collagen  gels.  Immunoreactivity was  strong  in 
MVZ-infected cells (A and B), and was often observed in a punc- 
tate pattern within the cytoplasm (arrows). No signal was detect- 
able in the extracellular matrix (3-D  Gel).  CXL control virus-- 
infected and uninfected cultures (C and D) did not show any re- 
activity. Bars, 20 p~m. 
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Figure 7.  Expression of type V collagen is reduced by infection 
with the al(V) minigene. Cells infected with the MVZ virus syn- 
thesize reduced levels of type V collagen. Type V and type I col- 
lagen levels were measured from cultures that had been infected 
with the type V minigene--eontaining virus (MVZ), control virus 
(CXL), or from uninfected cultures. Type IN ratios were mea- 
sured by densitometric scans of the a2(I) and al(V) bands. Lev- 
els of type V collagen have been normalized to the quantities of 
type I collagen. These data demonstrate that expression  from 
the type V minigene--containing virus results in a 25% reduction 
of type V collagen relative to uninfected or control virus-infected 
cultures. Values are expressed as the mean _ SEM, n = 7. 
Discussion 
The  regulation  of collagen  fibril  assembly  is  critical  to 
achieve tissue-specific matrix architecture. We have shown 
that reducing the type V collagen levels in type I/V fibrils 
abolishes  this  regulation and  results  in  the  assembly of 
fibrils with an abnormally large diameter. These data indi- 
cate that assembly of cornea-specific fibrils is an autoregu- 
latory process. Fibrillogenesis is regulated by the compo- 
nents that comprise the fibril and, in this case, it is  the 
quantitatively minor type V  collagen within heterotypic 
fibrils that performs this regulatory function (3, 4, 19). Our 
previous studies in vitro implicated the concentration of 
type V collagen as being partially responsible for regulat- 
ing fibril diameter (4). We also have shown that the cor- 
neal fibroblast produces a higher percentage of type V col- 
lagen (20%) than fibroblasts from other type I containing 
tissues, e.g., sclera and tendon (2-5%; 23). In addition, this 
is regulated by corneal fibroblast-specific cytoplasmic fac- 
tors that can upregulate type V  synthesis in noncorneal 
cell types (21). In the current studies, we demonstrate that 
the  concentration of type V  collagen alone is  necessary 
and sufficient for tissue-specific fibril assembly. 
Other examples of this type of heterotypic fibril regu- 
lation exist. Types XI and II collagen, for example, coas- 
semble as heterotypic fibrils in cartilage (24, 29) and loss 
of function mutations in the al(XI) chain lead to the as- 
sembly of collagen fibrils with abnormally large diameters 
(16, 34).  In addition, mutations that overexpress type II 
collagen result in a similarly altered XI/II ratio, and they 
also drive the assembly of large fibrils (13). Although it is 
likely that the al(V) and al(XI) chains have comparable 
regulatory functions since they are structurally very simi- 
lar, comparisons between these ~t chains are complicated 
by the fact that several alternatively spliced forms of type 
XI exist in different tissues (27, 32, 35, 37) and that hetero- 
typic XI/II fibrils also may contain type IX collagen on 
their surface (24). It is hkely that these modifications alter 
the  properties  of both the  fibrils  and  their interactions 
with the surrounding extracellular matrix. 
The dominant-negative strategy employed in the present 
study used a replication-defective retroviral vector to in- 
troduce  the  truncated  al(V)  protein  to  cultured  cells. 
Since infection rates were ~,30%, this allowed us to ana- 
lyze infected cells in a wild-type background. We observed 
altered fibril morphology adjacent to infected cells, while 
the matrix synthesized by neighboring uninfected cells was 
normal. This demonstrates that the alteration of type V 
collagen levels is sufficient to abolish fibril diameter regu- 
lation, specifically in infected cells, and that compensatory 
mechanisms, if they exist, do not operate in the context of 
isolated mutant cells. This approach can be used to target 
specific tissues in vivo and would allow the analysis of tis- 
sue-specific effects without  the  complications  that  may 
arise from a systemic knockout. 
Alternative approaches to alter collagen molecule con- 
centration  and/or function also  have  been  used.  Trans- 
genic  mutations,  for  example,  have  been  made  in  the 
o~2(V) chain in mice. The location of one such mutation 
encompasses the N-telopeptide and propeptidase cleavage 
site (1), and may prevent the formation of the "hinge" re- 
gion that allows the amino-propeptide to project onto the 
fibril surface (20). Moreover, the molecules may be unable 
to participate in fibrillogenesis at all; the telopeptide do- 
mains removed as a result of the mutation are critical for 
normal chain assembly and fibrillogenesis (38). The ho- 
mozygotes have numerous connective tissue defects in a 
variety of tissues, including fragile skin, alterations in hair 
follicle distribution, and corneal fibril defects, including an 
increase in diameter (1). These tissues have disparate type V 
concentrations, and thus it is likely that the wide range of 
connective tissue defects observed may be related to rela- 
tively small changes in type V concentrations. Recent evi- 
dence  suggests  mutations  in  al(V)  collagen  in  Ehlers- 
Danlos patients lead to morphological changes in tissues, 
such as skin, that have comparatively low type V concen- 
trations (6). These results suggest important roles for type 
V collagen in matrix assembly in addition to the regulation 
of fibril diameter. 
The strategy we  used relies on the  fact that  collagen 
molecules assemble from the carboxyl termini of three ot 
chains. Expression of a truncated molecule that possesses 
a complete carboxyl terminus yet lacks the remaining se- 
quences should result in the assembly of hybrid molecules 
that  contain  both  truncated  and  endogenous  ot  chains. 
These hybrid molecules are likely to be shunted to degra- 
dative pathways, effectively lowering the concentration of 
type V  collagen. The immunofluorescent localization of 
the truncated ot chains to the lysosomal compartment and 
the lack of extracellular signal are indicative of such intra- 
cellular degradation. Evidence in the literature also sug- 
gests that the assembled hybrid molecules are likely to be 
degraded.  Several  ostegenesis  imperfecta variants  have 
defects that delete large triple-helical portions of the af- 
fected a  chains but that leave the C-propeptide unaffected. 
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Figure 8.  Ceils expressing the od(V) minigene assemble abnormally large diameter fibrils. Morphology of collagen fibrils assembled by 
MVZ- and CXL-infected corneal fibroblasts in three-dimensional collagen gel cultures. Immunostaining for cytoplasmic 13-galactosidase 
was used to identify infected cells (gold particles in cytoplasm). CXL-infected cells (A and C) produced normal fibrils with respect to diam- 
eter and size distribution. A total of 31 fibrils were measured from 7 positive cells. The morphology of fibrils synthesized from CXL- 
negative cells was indistinguishable from the positive ceils (not shown). MVZ-infected cells (B and D) produced large-diameter fibrils 
with a size distribution from 20 to 65 nm (mean 37.2 nm). Data were collected from 14 cells and 62 fibrils were measured. Bar, 150 nm. 
In these cases, transcription is normal, but chain assembly 
is severely compromised and results in procollagen suicide 
(30, 41). The demonstration that endogenous etl(V) pro- 
tein is reduced in MVZ-infected cultures indicates that the 
mutant ot chain is capable of this same trans-dominant  ef- 
fect on type V procollagen biosynthesis. 
In the MVZ virus-infected cells, levels of the truncated 
etl (V) minigene transcripts are severalfold higher than the 
endogenous  ctl(V)  mRNAs.  Given  that  these  truncated 
mRNAs  share  the  same  translation  initiation  and  signal 
sequences  as the endogenous mRNAs, they should com- 
pete  effectively  for  translation  and  generate  a  high  mu- 
tant/endogenous  protein ratio.  Such  high ratios  could be 
sufficient  to  entirely  block  endogenous  type  V  collagen 
synthesis in the infected cells by strongly favoring hybrid 
molecule formation over native chain assembly. This, in fact, 
is observed.  The  data  comparing protein synthesis in in- 
fected and uninfected cells shows a 25% decrease in o~l(V) 
protein in MVZ-infected  cultures.  Since  only 30-40%  of 
the synthesized  matrix  is  the product of transgenic cells, 
this decrease reflects a significant reduction in the infected 
cells; the observed otl(V) protein may be solely the prod- 
uct of uninfected cells. 
We observed nonspecific reductions in both type I and V 
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Figure 9.  Cells expressing the ~tl(V) minigene produce large diameter fibrils while nonexpressing cells in the same culture produce 
small diameter fibrils. Collagen fibril morphology in MVZ-infected and uninfected chicken embryo fibroblasts cultured in collagen gels 
(G). Uninfected cells (MVZ-) produced normal 24-nm-diameter fibrils with a narrow size distribution (A and C). In MVZ-irdeeted cells 
(MVZ+), the synthesized fibrils had a much broader size distribution, ranging from 20 to 60 nm with a mean of 44 nm (B and D). Several 
large diameter fibrils are visible in extracytoplasmic channels and the site of fibril assembly, and were seen as membrane delimited 
fibrils within the cytoplasm. Bar, 150 nm. 
collagen synthesis as a result of the viral (CXL and MVZ) 
infection.  These  were  observed  at  both  the  mRNA  and 
protein  levels.  However,  these  reductions  did  not  affect 
the ratio of types I  and V  collagen. This ratio was altered 
only in the MVZ-infected  cultures,  and was therefore  at- 
tributable  to the expression  of the type V  minigene.  The 
appearance  of normal  corneal  fibrils  in  the  CXL-infected 
cells indicates  that these viral alterations  do not result in 
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type V collagen  is inversely  re- 
lated  to  fibril  diameter.  Anti- 
bodies  directed  against  the 
amino-terminal domain of type 
V collagen were used to localize 
this protein on fibrils assembled 
by the MVZ- and CXL-infected 
cells. Previous studies in our lab- 
oratory have demonstrated that 
this  domain is  exposed on the 
surface  of heterotypic type I/V 
fibrils.  Small-diameter  fibrils 
produced  by the  CXL-infected 
cells demonstrated reactivity (A, 
C, and E) while the large fibrils 
assembled by the MVZ-infected 
cells were negative (B,  D, and 
F). Bar, 150 nm. 
the loss of a  differentiated phenotype; the  alterations in 
fibril morphology and in the IN ratios were only observed 
in the MVZ-infected cells. 
Collagen fibril diameter is altered in cells infected with 
the  MVZ virus. Analysis of fibrils assembled by the  in- 
fected  cells  revealed  that  diameters  were  considerably 
larger  than  in  control  virus-infected  or  uninfected  cul- 
tures. These fibrils also had a much broader size distribu- 
tion  than did the  controls. The overall morphology and 
spacing of the fibrils assembled by the MVZ-infected cells 
is similar to that observed in situ in other tissues, e.g., ten- 
don and sclera. In these tissues, the levels of type V  col- 
lagen differ substantially from the levels found in the cor- 
nea. Type V  collagen represents  15-20%  of the fibrillar 
collagen in cornea, while it is only 2-5% in these other tis- 
sues (23). We have demonstrated that infection of corneal 
fibroblasts with recombinant virus lowers the endogenous 
type V collagen production. In these cells, the morphology 
of the  fibrils  synthesized  resembles  the  morphology of 
fibrils synthesized by cells that normally produce compa- 
rably low type V  collagen levels. This strongly indicates a 
direct relationship between type V collagen concentration 
and  fibril  diameter.  Our  demonstration  that  the  large- 
diameter fibrils show little or no reactivity with anti-type 
V antibodies is consistent with this contention. 
The  dominant-negative  strategy chosen  to reduce  the 
levels of type V collagen was designed to express high lev- 
els of a truncated ot chain that would compete effectively 
with the endogenous ot chains for assembly into triple-heli- 
cal  molecules.  The  mutant-endogenous  hybrid  trimers 
would be targeted to degradative pathways. With high ex- 
pression of the mutant chains, the concentration of func- 
tional  type V  molecules,  composed entirely  of native ot 
chains, would be decreased. The altered fibril morphology 
we observed is most likely the result of the change in type 
IN  collagen ratios within the heterotypic fibrils that re- 
suits from the lowered type V collagen available during as- 
sembly type IN heterotypic fibrils. It is also possible that 
in addition to the mutant-endogenous hybrid formation, 
mutant homotrimers assemble as "mini collagens". How- 
ever, our immunofluorescent and Western  analyses sug- 
gest that if such molecules form, they are rapidly degraded 
or are accumulated in the cells, since no mutant protein 
was detectable by either assay in the extracellular matrix. 
A  model for the regulation of fibril diameter in hetero- 
typic fibrils is presented  in Fig.  11.  We suggest that the 
amino-terminal domains of the type V collagen molecules 
Diameter Regulation 
A 
Steric 
B  ~---Type  V  Type J 
Figure 11.  Model for type V regulation of collagen fibril diame- 
ter. Collagen fibrils within the cornea contain  a high percentage 
of type V collagen and have small diameters (A, left), while fibrils 
in  other tissues  possessing  low levels  of type V  collagen  have 
large diameters (A, right). The experimental reduction of type V 
collagen  described  in this  paper generates fibrils that have the 
characteristics  of those found in tissues with low type V levels. A 
mechanism by which type V collagen may limit fibril growth is 
shown  in B. Type V  amino-terminal domains project onto the 
fibril  surface,  and when sufficient  numbers have accumulated, 
they block further accretion of collagen monomers and thereby 
limit growth in diameter. The amino-terminal domain is large and 
possesses  a  number of acidic residues,  and so may affect this 
block using steric and/or electrostatic hindrance. 
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further accretion of collagen monomers. This would limit 
fibril growth by steric or electrostatic mechanisms. Steric 
mechanisms might involve interactions with other extra- 
cellular matrix components. Reduction of the type V mol- 
ecules within the fibrils would eliminate this barrier and 
thus  allow  unhindered  accretion  and  growth.  Our  data 
suggest that high levels of type V  collagen are critical for 
the regulated assembly of small-diameter fibrils in the cor- 
nea, and that perturbation of this collagen is sufficient to 
lose this tissue-specific phenotype. 
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